These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16114097)
1. Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes. Glassford J; Vigorito E; Soeiro I; Madureira PA; Zoumpoulidou G; Brosens JJ; Turner M; Lam EW Eur J Immunol; 2005 Sep; 35(9):2748-61. PubMed ID: 16114097 [TBL] [Abstract][Full Text] [Related]
2. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells. Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661 [TBL] [Abstract][Full Text] [Related]
3. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865 [TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells. Piatelli MJ; Wardle C; Blois J; Doughty C; Schram BR; Rothstein TL; Chiles TC J Immunol; 2004 Mar; 172(5):2753-62. PubMed ID: 14978074 [TBL] [Abstract][Full Text] [Related]
5. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes. Piatelli MJ; Doughty C; Chiles TC J Biol Chem; 2002 Apr; 277(14):12144-50. PubMed ID: 11823472 [TBL] [Abstract][Full Text] [Related]
6. Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. Bilancio A; Okkenhaug K; Camps M; Emery JL; Ruckle T; Rommel C; Vanhaesebroeck B Blood; 2006 Jan; 107(2):642-50. PubMed ID: 16179367 [TBL] [Abstract][Full Text] [Related]
7. Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen Receptor. Glassford J; Holman M; Banerji L; Clayton E; Klaus GG; Turner M; Lam EW J Biol Chem; 2001 Nov; 276(44):41040-8. PubMed ID: 11546804 [TBL] [Abstract][Full Text] [Related]
8. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells. Bone H; Williams NA Int Immunol; 2001 Jun; 13(6):807-16. PubMed ID: 11369709 [TBL] [Abstract][Full Text] [Related]
9. Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses. Hess KL; Donahue AC; Ng KL; Moore TI; Oak J; Fruman DA Eur J Immunol; 2004 Nov; 34(11):2968-76. PubMed ID: 15384044 [TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase activation in normal human B lymphocytes. Aagaard-Tillery KM; Jelinek DF J Immunol; 1996 Jun; 156(12):4543-54. PubMed ID: 8648095 [TBL] [Abstract][Full Text] [Related]
11. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway. Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972 [TBL] [Abstract][Full Text] [Related]
12. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794 [TBL] [Abstract][Full Text] [Related]
13. Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. Lam EW; Glassford J; Banerji L; Thomas NS; Sicinski P; Klaus GG J Biol Chem; 2000 Feb; 275(5):3479-84. PubMed ID: 10652342 [TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation. Iwakiri D; Takada K J Immunol; 2004 Feb; 172(3):1561-6. PubMed ID: 14734735 [TBL] [Abstract][Full Text] [Related]
15. Immature stage B cells enter but do not progress beyond the early G1 phase of the cell cycle in response to antigen receptor signaling. Carman JA; Wechsler-Reya RJ; Monroe JG J Immunol; 1996 Jun; 156(12):4562-9. PubMed ID: 8648097 [TBL] [Abstract][Full Text] [Related]
16. Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture. Kawada N; Ikeda K; Seki S; Kuroki T J Hepatol; 1999 Jun; 30(6):1057-64. PubMed ID: 10406184 [TBL] [Abstract][Full Text] [Related]
17. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma. Mizuno T; Rothstein TL J Immunol; 2005 May; 174(10):6062-70. PubMed ID: 15879100 [TBL] [Abstract][Full Text] [Related]
18. Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation. Al-Alwan MM; Okkenhaug K; Vanhaesebroeck B; Hayflick JS; Marshall AJ J Immunol; 2007 Feb; 178(4):2328-35. PubMed ID: 17277138 [TBL] [Abstract][Full Text] [Related]
19. BCR activation of PI3K is Vav-independent in murine B cells. Vigorito E; Clayton E; Turner M Biochem Soc Trans; 2004 Nov; 32(Pt 5):781-4. PubMed ID: 15494014 [TBL] [Abstract][Full Text] [Related]
20. A possible signal transduction pathway for cyclin D2 expression by a pectic polysaccharide from the roots of bupleurum falcatum L. in murine B cell. Matsumoto T; Hosono-Nishiyama K; Guo YJ; Ikejima T; Yamada H Int Immunopharmacol; 2005 Aug; 5(9):1373-86. PubMed ID: 15953564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]